Global Asthma & COPD Market Insights, Forecast to 2025

Report Code: AMR- 1-80241

Category: Pharma & Healthcare

Published Date: 2019-05-13

Format: Electronic PDF

Pages: 112

Chronic obstructive pulmonary disease (COPD) is a general term that describes progressive respiratory diseases like emphysema and chronic bronchitis. COPD is characterized by decreased airflow over time, as well as inflammation of the tissues that line the airway.
Asthma is usually considered a separate respiratory disease, but sometimes its mistaken for COPD. The two have similar symptoms. These symptoms include chronic coughing, wheezing, and shortness of breath.
Currently, North America leads the global market for asthma & COPD drugs and devices. North America was followed by Europe in terms of market capitalization. However, North America and Europe is expected to lose out some of the market share to other emerging regional markets owing to the expiry of several patens of pharmaceutical companies operating in these regions. Asia Pacific is expected to be the fastest regional market for asthma and COPD owing to the increased incidence of asthma & other respiratory diseases in industrial regions.
The global Asthma & COPD market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Asthma & COPD market based on company, product type, end user and key regions.

This report studies the global market size of Asthma & COPD in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Asthma & COPD in these regions.
This research report categorizes the global Asthma & COPD market by top players/brands, region, type and end user. This report also studies the global Asthma & COPD market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GSK
Novartis
Merck
Abbott
Boehringer Ingelheim
AstraZeneca
Roche
Teva
Vectura
Pfizer
Mylan
Allergan
Cipla
Akorn

Market size by Product
Anti-inflammatory Drugs
Bronchodilator Monotherapy
Combination Drugs
Market size by End User
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Asthma & COPD market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Asthma & COPD market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Asthma & COPD companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Asthma & COPD submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Asthma & COPD are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Asthma & COPD market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
    1.1  Asthma & COPD Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Asthma & COPD Market Size Growth Rate by Product
        1.4.2 Anti-inflammatory Drugs
        1.4.3 Bronchodilator Monotherapy
        1.4.4 Combination Drugs
    1.5 Market by End User
        1.5.1 Global Asthma & COPD Market Size Growth Rate by End User
        1.5.2 Hospital Pharmacies
        1.5.3 Private Clinics
        1.5.4 Drug Stores
        1.5.5 Retail Pharmacies
        1.5.6 E-Commerce
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Asthma & COPD Market Size
        2.1.1 Global Asthma & COPD Revenue 2014-2025
        2.1.2 Global Asthma & COPD Sales 2014-2025
    2.2 Asthma & COPD Growth Rate by Regions
        2.2.1 Global Asthma & COPD Sales by Regions
        2.2.2 Global Asthma & COPD Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Asthma & COPD Sales by Manufacturers
        3.1.1 Asthma & COPD Sales by Manufacturers
        3.1.2 Asthma & COPD Sales Market Share by Manufacturers
        3.1.3 Global Asthma & COPD Market Concentration Ratio (CR5 and HHI)
    3.2 Asthma & COPD Revenue by Manufacturers
        3.2.1 Asthma & COPD Revenue by Manufacturers (2014-2019)
        3.2.2 Asthma & COPD Revenue Share by Manufacturers (2014-2019)
    3.3 Asthma & COPD Price by Manufacturers
    3.4 Asthma & COPD Manufacturing Base Distribution, Product Types
        3.4.1 Asthma & COPD Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Asthma & COPD Product Type
        3.4.3 Date of International Manufacturers Enter into Asthma & COPD  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
    4.1 Global Asthma & COPD Sales by Product
    4.2 Global Asthma & COPD Revenue by Product
    4.3 Asthma & COPD Price by Product

5 Breakdown Data by End User
    5.1 Overview
    5.2 Global Asthma & COPD Breakdown Data by End User

6 North America
    6.1 North America Asthma & COPD by Countries
        6.1.1 North America Asthma & COPD Sales by Countries
        6.1.2 North America Asthma & COPD Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Asthma & COPD by Product
    6.3 North America Asthma & COPD by End User

7 Europe
    7.1 Europe Asthma & COPD by Countries
        7.1.1 Europe Asthma & COPD Sales by Countries
        7.1.2 Europe Asthma & COPD Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Asthma & COPD by Product
    7.3 Europe Asthma & COPD by End User

8 Asia Pacific
    8.1 Asia Pacific Asthma & COPD by Countries
        8.1.1 Asia Pacific Asthma & COPD Sales by Countries
        8.1.2 Asia Pacific Asthma & COPD Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Asthma & COPD by Product
    8.3 Asia Pacific Asthma & COPD by End User

9 Central & South America
    9.1 Central & South America Asthma & COPD by Countries
        9.1.1 Central & South America Asthma & COPD Sales by Countries
        9.1.2 Central & South America Asthma & COPD Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Asthma & COPD by Product
    9.3 Central & South America Asthma & COPD by End User

10 Middle East and Africa
    10.1 Middle East and Africa Asthma & COPD by Countries
        10.1.1 Middle East and Africa Asthma & COPD Sales by Countries
        10.1.2 Middle East and Africa Asthma & COPD Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Asthma & COPD by Product
    10.3 Middle East and Africa Asthma & COPD by End User

11 Company Profiles
    11.1 GSK
        11.1.1 GSK Company Details
        11.1.2 Company Business Overview
        11.1.3 GSK Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
        11.1.4 GSK Asthma & COPD Products Offered
        11.1.5 GSK Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Company Business Overview
        11.2.3 Novartis Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
        11.2.4 Novartis Asthma & COPD Products Offered
        11.2.5 Novartis Recent Development
    11.3 Merck
        11.3.1 Merck Company Details
        11.3.2 Company Business Overview
        11.3.3 Merck Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
        11.3.4 Merck Asthma & COPD Products Offered
        11.3.5 Merck Recent Development
    11.4 Abbott
        11.4.1 Abbott Company Details
        11.4.2 Company Business Overview
        11.4.3 Abbott Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
        11.4.4 Abbott Asthma & COPD Products Offered
        11.4.5 Abbott Recent Development
    11.5 Boehringer Ingelheim
        11.5.1 Boehringer Ingelheim Company Details
        11.5.2 Company Business Overview
        11.5.3 Boehringer Ingelheim Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
        11.5.4 Boehringer Ingelheim Asthma & COPD Products Offered
        11.5.5 Boehringer Ingelheim Recent Development
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Details
        11.6.2 Company Business Overview
        11.6.3 AstraZeneca Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
        11.6.4 AstraZeneca Asthma & COPD Products Offered
        11.6.5 AstraZeneca Recent Development
    11.7 Roche
        11.7.1 Roche Company Details
        11.7.2 Company Business Overview
        11.7.3 Roche Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
        11.7.4 Roche Asthma & COPD Products Offered
        11.7.5 Roche Recent Development
    11.8 Teva
        11.8.1 Teva Company Details
        11.8.2 Company Business Overview
        11.8.3 Teva Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
        11.8.4 Teva Asthma & COPD Products Offered
        11.8.5 Teva Recent Development
    11.9 Vectura
        11.9.1 Vectura Company Details
        11.9.2 Company Business Overview
        11.9.3 Vectura Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
        11.9.4 Vectura Asthma & COPD Products Offered
        11.9.5 Vectura Recent Development
    11.10 Pfizer
        11.10.1 Pfizer Company Details
        11.10.2 Company Business Overview
        11.10.3 Pfizer Asthma & COPD Sales, Revenue and Gross Margin (2014-2019)
        11.10.4 Pfizer Asthma & COPD Products Offered
        11.10.5 Pfizer Recent Development
    11.11 Mylan
    11.12 Allergan
    11.13 Cipla
    11.14 Akorn

12 Future Forecast
    12.1 Asthma & COPD Market Forecast by Regions
        12.1.1 Global Asthma & COPD Sales Forecast by Regions 2019-2025
        12.1.2 Global Asthma & COPD Revenue Forecast by Regions 2019-2025
    12.2 Asthma & COPD Market Forecast by Product
        12.2.1 Global Asthma & COPD Sales Forecast by Product 2019-2025
        12.2.2 Global Asthma & COPD Revenue Forecast by Product 2019-2025
    12.3 Asthma & COPD Market Forecast by End User
    12.4 North America Asthma & COPD Forecast
    12.5 Europe Asthma & COPD Forecast
    12.6 Asia Pacific Asthma & COPD Forecast
    12.7 Central & South America Asthma & COPD Forecast
    12.8 Middle East and Africa Asthma & COPD Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Asthma & COPD Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables and Figures

    Figure Asthma & COPD Product Picture
    Table Asthma & COPD Market Segments
    Table Key Manufacturers Asthma & COPD Covered
    Table Global Asthma & COPD Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
    Figure Global Asthma & COPD Sales Market Share by Product 2014-2025
    Figure Anti-inflammatory Drugs Product Picture
    Table Major Manufacturers of Anti-inflammatory Drugs
    Figure Bronchodilator Monotherapy Product Picture
    Table Major Manufacturers of Bronchodilator Monotherapy
    Figure Combination Drugs Product Picture
    Table Major Manufacturers of Combination Drugs
    Table Global Asthma & COPD Market Size Growth Rate by End User 2019-2025 (K Units)
    Figure Hospital Pharmacies
    Figure Private Clinics
    Figure Drug Stores
    Figure Retail Pharmacies
    Figure E-Commerce
    Figure Asthma & COPD Report Years Considered
    Figure Global Asthma & COPD Market Size 2014-2025 (Million US$)
    Figure Global Asthma & COPD Sales 2014-2025 (K Units)
    Table Global Asthma & COPD Market Size by Regions 2014-2019 (K Units) & (Million US$)
    Table Global Asthma & COPD Sales by Regions 2014-2019 (K Units)
    Table Global Asthma & COPD Sales Market Share by Regions 2014-2019
    Figure Global Asthma & COPD Sales Market Share by Regions 2014-2019
    Figure 2018 Global Asthma & COPD Sales Market Share by Regions
    Table Global Asthma & COPD Revenue by Regions 2014-2019 (Million US$)
    Table Global Asthma & COPD Revenue Market Share by Regions 2014-2019
    Figure Global Asthma & COPD Revenue Market Share by Regions 2014-2019
    Figure 2018 Global Asthma & COPD Revenue Market Share by Regions
    Table Global Asthma & COPD Sales by Manufacturers (2014-2019) (K Units)
    Table Global Asthma & COPD Sales Share by Manufacturers (2014-2019)
    Figure Global Asthma & COPD Sales Share by Manufacturers in 2018
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Asthma & COPD Revenue by Manufacturers (2014-2019) (Million USD)
    Table Asthma & COPD Revenue Share by Manufacturers (2014-2019)
    Figure Asthma & COPD Value Share by Manufacturers in 2018
    Table Key Manufacturers Asthma & COPD Price (2014-2019) (USD/Unit)
    Table Asthma & COPD Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Asthma & COPD Product Type
    Table Date of International Manufacturers Enter into Asthma & COPD Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Asthma & COPD Sales by Product (2014-2019) (K Units)
    Table Global Asthma & COPD Sales Share by Product (2014-2019)
    Figure Global Asthma & COPD Sales Market Share by Product (2014-2019)
    Figure Global Asthma & COPD Sales Market Share by Product in 2018
    Table Global Asthma & COPD Revenue by Product (2014-2019) (Million US$)
    Table Global Asthma & COPD Revenue Share by Product (2014-2019)
    Figure Global Asthma & COPD Revenue Market Share by Product (2014-2019)
    Figure Global Asthma & COPD Revenue Market Share by Product in 2018
    Table Asthma & COPD Price by Product 2014-2019 (USD/Unit)
    Table Global Asthma & COPD Sales by End User (2014-2019) (K Units)
    Table Global Asthma & COPD Sales Share by End User (2014-2019)
    Figure Global Sales Asthma & COPD Market Share by End User (2014-2019)
    Figure Global Sales Asthma & COPD Market Share by End User in 2018
    Figure North America Asthma & COPD Sales Growth Rate 2014-2019 (K Units)
    Figure North America Asthma & COPD Revenue Growth Rate 2014-2019 (Million US$)
    Table North America Asthma & COPD Sales by Countries (2014-2019) (K Units)
    Table North America Asthma & COPD Sales Market Share by Countries (2014-2019)
    Figure 2018 North America Asthma & COPD Sales Market Share by Countries
    Table North America Asthma & COPD Revenue by Countries (2014-2019) (Million US$)
    Table North America Asthma & COPD Revenue Market Share by Countries (2014-2019)
    Figure 2018 North America Asthma & COPD Revenue Market Share by Countries
    Figure United States Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure United States Asthma & COPD Revenue Growth Rate (2014-2019) (K Units)
    Figure Canada Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure Canada Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Figure Mexico Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure Mexico Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Table North America Asthma & COPD Sales by Product (2014-2019) (K Units)
    Table North America Asthma & COPD Sales Market Share by Product (2014-2019)
    Figure 2018 North America Asthma & COPD Market Share by Product
    Table North America Asthma & COPD Sales by End User (2014-2019) (K Units)
    Table North America Asthma & COPD Sales Market Share by End User (2014-2019)
    Figure 2018 North America Asthma & COPD Market Share by End User
    Figure Europe Asthma & COPD Sales Growth Rate 2014-2019 (K Units)
    Figure Europe Asthma & COPD Revenue Growth Rate 2014-2019 (Million US$)
    Table Europe Asthma & COPD Sales by Countries (2014-2019) (K Units)
    Table Europe Asthma & COPD Sales Market Share by Countries (2014-2019)
    Figure 2018 Europe Asthma & COPD Sales Market Share by Countries
    Table Europe Asthma & COPD Revenue by Countries (2014-2019) (Million US$)
    Table Europe Asthma & COPD Revenue Market Share by Countries (2014-2019)
    Figure 2018 Europe Asthma & COPD Revenue Market Share by Countries
    Figure Germany Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure Germany Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Figure France Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure France Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Figure UK Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure UK Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Figure Italy Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure Italy Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Figure Russia Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure Russia Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Table Europe Asthma & COPD Sales by Product (2014-2019) (K Units)
    Table Europe Asthma & COPD Sales Market Share by Product (2014-2019)
    Figure 2018 Europe Asthma & COPD Market Share by Product
    Table Europe Asthma & COPD Sales by End User (2014-2019) (K Units)
    Table Europe Asthma & COPD Sales Market Share by End User (2014-2019)
    Figure 2018 Europe Asthma & COPD Market Share by End User
    Figure Asia Pacific Asthma & COPD Sales Growth Rate 2014-2019 (K Units)
    Figure Asia Pacific Asthma & COPD Revenue Growth Rate 2014-2019 (Million US$)
    Table Asia Pacific Asthma & COPD Sales by Countries (2014-2019) (K Units)
    Table Asia Pacific Asthma & COPD Sales Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Asthma & COPD Sales Market Share by Countries
    Table Asia Pacific Asthma & COPD Revenue by Countries (2014-2019) (Million US$)
    Table Asia Pacific Asthma & COPD Revenue Market Share by Countries (2014-2019)
    Figure 2018 Asia Pacific Asthma & COPD Revenue Market Share by Countries
    Figure China Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure China Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Figure Japan Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure Japan Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Figure Korea Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure Korea Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Figure India Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure India Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Figure Australia Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure Australia Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Figure Indonesia Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure Indonesia Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Figure Malaysia Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure Malaysia Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Figure Philippines Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure Philippines Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Figure Thailand Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure Thailand Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Figure Vietnam Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure Vietnam Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Figure Singapore Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure Singapore Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Table Asia Pacific Asthma & COPD Sales by Product (2014-2019) (K Units)
    Table Asia Pacific Asthma & COPD Sales Market Share by Product (2014-2019)
    Figure 2018 Asia Pacific Asthma & COPD Market Share by Product
    Table Asia Pacific Asthma & COPD Sales by End User (2014-2019) (K Units)
    Table Asia Pacific Asthma & COPD Sales Market Share by End User (2014-2019)
    Figure 2018 Asia Pacific Asthma & COPD Market Share by End User
    Figure Central & South America Asthma & COPD Sales Growth Rate 2014-2019 (K Units)
    Figure Central & South America Asthma & COPD Revenue Growth Rate 2014-2019 (Million US$)
    Table Central & South America Asthma & COPD Sales by Countries (2014-2019) (K Units)
    Table Central & South America Asthma & COPD Sales Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Asthma & COPD Sales Market Share by Countries
    Table Central & South America Asthma & COPD Revenue by Countries (2014-2019) (Million US$)
    Table Central & South America Asthma & COPD Revenue Market Share by Countries (2014-2019)
    Figure 2018 Central & South America Asthma & COPD Revenue Market Share by Countries
    Figure Brazil Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure Brazil Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Figure Argentina Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure Argentina Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Table Central & South America Asthma & COPD Sales by Product (2014-2019) (K Units)
    Table Central & South America Asthma & COPD Sales Market Share by Product (2014-2019)
    Figure 2018 Central & South America Asthma & COPD Market Share by Product
    Table Central & South America Asthma & COPD Sales by End User (2014-2019) (K Units)
    Table Central & South America Asthma & COPD Sales Market Share by End User (2014-2019)
    Figure 2018 Central & South America Asthma & COPD Market Share by End User
    Figure Middle East and Africa Asthma & COPD Sales Growth Rate 2014-2019 (K Units)
    Figure Middle East and Africa Asthma & COPD Revenue Growth Rate 2014-2019 (Million US$)
    Table Middle East and Africa Asthma & COPD Sales by Countries (2014-2019) (K Units)
    Table Middle East and Africa Asthma & COPD Sales Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Asthma & COPD Sales Market Share by Countries
    Table Middle East and Africa Asthma & COPD Revenue by Countries (2014-2019) (Million US$)
    Table Middle East and Africa Asthma & COPD Revenue Market Share by Countries (2014-2019)
    Figure 2018 Middle East and Africa Asthma & COPD Revenue Market Share by Countries
    Figure GCC Countries Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure GCC Countries Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Figure Turkey Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure Turkey Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Figure Egypt Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure Egypt Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Figure South Africa Asthma & COPD Sales Growth Rate (2014-2019) (K Units)
    Figure South Africa Asthma & COPD Revenue Growth Rate (2014-2019) (Million US$)
    Table Middle East and Africa Asthma & COPD Sales by Product (2014-2019) (K Units)
    Table Middle East and Africa Asthma & COPD Sales Market Share by Product (2014-2019)
    Figure 2018 Middle East and Africa Asthma & COPD Market Share by Product
    Table Middle East and Africa Asthma & COPD Sales by End User (2014-2019) (K Units)
    Table Middle East and Africa Asthma & COPD Sales Market Share by End User (2014-2019)
    Figure 2018 Middle East and Africa Asthma & COPD Market Share by End User
    Table GSK Company Details
    Table GSK Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table GSK Recent Development

    Table Novartis Company Details
    Table Novartis Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Novartis Recent Development

    Table Merck Company Details
    Table Merck Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Merck Recent Development

    Table Abbott Company Details
    Table Abbott Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Abbott Recent Development

    Table Boehringer Ingelheim Company Details
    Table Boehringer Ingelheim Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Boehringer Ingelheim Recent Development

    Table AstraZeneca Company Details
    Table AstraZeneca Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table AstraZeneca Recent Development

    Table Roche Company Details
    Table Roche Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Roche Recent Development

    Table Teva Company Details
    Table Teva Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Teva Recent Development

    Table Vectura Company Details
    Table Vectura Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Vectura Recent Development

    Table Pfizer Company Details
    Table Pfizer Asthma & COPD Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Pfizer Recent Development

    Table Mylan Company Details
    Table Allergan Company Details
    Table Cipla Company Details
    Table Akorn Company Details
    Table Global Asthma & COPD Sales Forecast by Regions 2019-2025 (K Units)
    Table Global Asthma & COPD Sales Market Share Forecast by Regions 2019-2025
    Table Global Asthma & COPD Revenue Forecast by Regions 2019-2025 (Million US$)
    Table Global Asthma & COPD Revenue Market Share Forecast by Regions 2019-2025
    Table Global Asthma & COPD Sales Forecast by Product 2019-2025 (K Units)
    Table Global Asthma & COPD Sales Market Share Forecast by Product 2019-2025
    Table Global Asthma & COPD Revenue Forecast by Product 2019-2025 (Million US$)
    Table Global Asthma & COPD Revenue Market Share Forecast by Product 2019-2025
    Table Global Asthma & COPD Sales Forecast by End User 2019-2025 (K Units)
    Table Global Asthma & COPD Sales Market Share Forecast by End User 2019-2025
    Figure North America Asthma & COPD Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure North America Asthma & COPD Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Europe Asthma & COPD Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Europe Asthma & COPD Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Asia Pacific Asthma & COPD Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Asia Pacific Asthma & COPD Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Central & South America Asthma & COPD Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Central & South America Asthma & COPD Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Figure Middle East and Africa Asthma & COPD Sales Growth Rate Forecast (2019-2025) (K Units)
    Figure Middle East and Africa Asthma & COPD Revenue Growth Rate Forecast (2019-2025) (Million US$)
    Table Asthma & COPD Value Chain
    Table Asthma & COPD Customers List
    Table Asthma & COPD Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Full Name *
Business Email *
Designation
Company *
Country *
Phone No. *

Message
Security Code *
207
Invalid Input